LLY

1,014.11

-2.29%↓

JNJ

202.6

-1.25%↓

ABBV

228.53

-0.44%↓

UNH

331.72

-2.21%↓

AZN

90.3

-0.56%↓

LLY

1,014.11

-2.29%↓

JNJ

202.6

-1.25%↓

ABBV

228.53

-0.44%↓

UNH

331.72

-2.21%↓

AZN

90.3

-0.56%↓

LLY

1,014.11

-2.29%↓

JNJ

202.6

-1.25%↓

ABBV

228.53

-0.44%↓

UNH

331.72

-2.21%↓

AZN

90.3

-0.56%↓

LLY

1,014.11

-2.29%↓

JNJ

202.6

-1.25%↓

ABBV

228.53

-0.44%↓

UNH

331.72

-2.21%↓

AZN

90.3

-0.56%↓

LLY

1,014.11

-2.29%↓

JNJ

202.6

-1.25%↓

ABBV

228.53

-0.44%↓

UNH

331.72

-2.21%↓

AZN

90.3

-0.56%↓

Search

ABIOMED Inc

Atvērts

SektorsVeselības aprūpe

0

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

Max

Rekomendācijas

By TipRanks

Rekomendācijas

Neitrāls

Prognoze 12 mēnešiem

-4.99% downside

Ziņu noskaņojums

By Acuity

50%

50%

167 / 374 Rangs Healthcare

ABIOMED Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 3. dec. 23:21 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

EQB to Buy Loblaw Unit PC Financial for About $573.5 Million -- Update

2025. g. 3. dec. 23:14 UTC

Iegādes, apvienošanās, pārņemšana

EQB to Buy PC Financial From Loblaw for About $573.5 Million

2025. g. 3. dec. 22:01 UTC

Galvenie tirgus virzītāji

Costco Wholesale Reports Higher Monthly Sales

2025. g. 3. dec. 21:38 UTC

Peļņas

Salesforce Raises Revenue Forecast as Agentforce Sales Top $500 Million

2025. g. 3. dec. 23:59 UTC

Tirgus saruna

Australian Coal Prices Seen Having Recovered Well -- Market Talk

2025. g. 3. dec. 23:49 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 3. dec. 23:49 UTC

Tirgus saruna

HSBC Chair Appointment Unlikely to Have Material Operational Impact -- Market Talk

2025. g. 3. dec. 23:49 UTC

Tirgus saruna

Nikkei May Decline Amid Caution Over U.S. Labor Market -- Market Talk

2025. g. 3. dec. 23:13 UTC

Tirgus saruna

Australian Treasurer Says Economy Not On Drip of Govt Spending -- Market Talk

2025. g. 3. dec. 23:10 UTC

Peļņas

Salesforce Raises Forecast as Agentforce Sales Top $500M -- Update

2025. g. 3. dec. 23:08 UTC

Tirgus saruna

Goodman's New Bull Sees Profit Upgrade on Cards -- Market Talk

2025. g. 3. dec. 23:06 UTC

Iegādes, apvienošanās, pārņemšana

EQB to Buy Loblaw Unit PC Financial for About $573.5M -- Update

2025. g. 3. dec. 22:59 UTC

Iegādes, apvienošanās, pārņemšana

EQB to Buy PC Financial From Loblaw for About $573.5M

2025. g. 3. dec. 22:45 UTC

Tirgus saruna

WiseTech Investor Day Increases Bull's Confidence -- Market Talk

2025. g. 3. dec. 22:20 UTC

Peļņas

Salesforce CEO: 9,500 of 18,500 Total Closed Agentforce Deals Are Paid

2025. g. 3. dec. 22:19 UTC

Peļņas

Salesforce CEO: Six Out of 10 Biggest Deals in 3Q Came from Agentforce

2025. g. 3. dec. 22:17 UTC

Peļņas

Salesforce Working to Add Voice to Agentforce, CEO Says

2025. g. 3. dec. 22:16 UTC

Peļņas

Salesforce CEO: Williams-Sonoma's Agentforce Makes Up 60% of Customer Chats

2025. g. 3. dec. 22:15 UTC

Peļņas

Salesforce CEO: Agentforce ARR Was $540M in 3Q

2025. g. 3. dec. 22:10 UTC

Iegādes, apvienošanās, pārņemšana

EQB: Will Enter Into a Long-Term Strategic Relationship With Loblaw >EQB.T

2025. g. 3. dec. 22:09 UTC

Iegādes, apvienošanās, pārņemšana

EQB: Agreed to Acquire PC Fincl From Loblaw >EQB.T

2025. g. 3. dec. 21:50 UTC

Tirgus saruna

Auto & Transport Roundup: Market Talk

2025. g. 3. dec. 21:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 3. dec. 21:49 UTC

Peļņas

Salesforce Reports Mounting Profits. The Stock Is Rising. -- Barrons.com

2025. g. 3. dec. 21:23 UTC

Peļņas

Salesforce Raises Revenue Forecast as Agentforce Sales Top $500M

2025. g. 3. dec. 21:19 UTC

Peļņas

Salesforce Reports Mounting Profits. The Stock Is Rising. -- Barrons.com

2025. g. 3. dec. 21:06 UTC

Peļņas

Salesforce Reports Mixed Earnings. The Stock Is Rising. -- Barrons.com

2025. g. 3. dec. 21:04 UTC

Peļņas

Salesforce Sees Profitable Growth Framework Target of 50 by FY30 >CRM

2025. g. 3. dec. 21:04 UTC

Peļņas

Salesforce Targets $60 B Plus Organic Rev by FY30 >CRM

2025. g. 3. dec. 21:03 UTC

Peļņas

Salesforce Raises FY26 Oper Cash Flow Growth Guidance to 13% to 14% Y/Y >CRM

Salīdzinājums

Cenas izmaiņa

ABIOMED Inc Prognoze

Cenas mērķis

By TipRanks

-4.99% uz leju

Prognoze 12 mēnešiem

Vidējais 362 USD  -4.99%

Augstākais 388 USD

Zemākais 300 USD

Pamatojoties uz 6 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi ABIOMED Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

6 ratings

1

Pirkt

5

Turēt

0

Pārdot

Noskaņojums

By Acuity

167 / 374 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

$

help-icon Live chat